| dc.contributor.author | Zhao, Sizheng Steven | |
| dc.contributor.author | Jones, Gareth T | |
| dc.contributor.author | Hughes, David M | |
| dc.contributor.author | Moots, Robert J | |
| dc.contributor.author | Goodson, Nicola J | |
| dc.date.accessioned | 2021-12-10T13:48:01Z | |
| dc.date.available | 2021-12-10T13:48:01Z | |
| dc.date.issued | 2021-12 | |
| dc.identifier.citation | Zhao , S S , Jones , G T , Hughes , D M , Moots , R J & Goodson , N J 2021 , ' Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis ' , Rheumatology , vol. 60 , no. 12 , pp. 5734–5742 . https://doi.org/10.1093/rheumatology/keab242 | en |
| dc.identifier.issn | 1462-0324 | |
| dc.identifier.other | PURE: 191493978 | |
| dc.identifier.other | PURE UUID: 4eed212b-cfff-4d85-a42d-243e8ebc6170 | |
| dc.identifier.other | PubMed: 33713118 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/93483281 | |
| dc.identifier.other | Scopus: 85122546134 | |
| dc.identifier.uri | https://hdl.handle.net/2164/17659 | |
| dc.description | Acknowledgment We are grateful to Professor Gary Macfarlane for commenting on the manuscript. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at: www.abdn.ac.uk/bsrbr-as. We also thank Dr Lewis Carpenter for suggesting splines for modelling time. Contribution: SSZ analysed the data and wrote the manuscript with significant input from all co- authors. GTJ is the Deputy Chief Investigator on BSRBR-AS and designed the study and oversaw its conduct. In the current project they discussed results and provided input into drafts of the manuscript. Funding: The BSRBR-AS is funded by the British Society for Rheumatology (BSR) who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. They have no input in determining the topics for analysis or work involved in undertaking it. | en |
| dc.format.extent | 9 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Rheumatology | en |
| dc.rights | © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | axial spondyloarthritis | en |
| dc.subject | depression | en |
| dc.subject | mental health | en |
| dc.subject | anxiety | en |
| dc.subject | treatment response | en |
| dc.subject | R Medicine | en |
| dc.subject | Other | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Clinical Medicine | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1093/rheumatology/keab242 | |
| dc.identifier.vol | 60 | en |
| dc.identifier.iss | 12 | en |
